Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one...

Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name...

acquired the brand from Novartis in 2002, except in the United States, where Nestlé acquired the rights separately from Novartis in the late 2000s. Ovaltine...

AveXis was acquired by Novartis in 2018 for USD 8.7 billion. In September 2020, Novartis changed the company's name to Novartis Gene Therapies. In 2019...

Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent...

2008, Novartis purchased approximately 25% of Nestlé's stake in Alcon, with an option to buy Nestlé's remaining shares beginning in 2010. Novartis bought...

sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer...

In February 2012, Novartis Consumer Health announced that they were temporarily, voluntarily suspending operations at the Novartis Consumer Health Lincoln...

The Novartis-Drew Award for Biomedical Research is an award jointly presented by Novartis and Drew University. It comprises a cash award (originally $2000)...

officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey Swiss Intel, canlgnd before joining Novartis in 2005...

the 1990s by researchers at Chiron Corporation, a Novartis heritage company, acquired by Novartis in 2006. AS03, another squalene based adjuvant O’Hagan...

combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed...

com. "Novartis Financial Results Q4 2023" (PDF). "Novartis Financial Results Q4 2022" (PDF). Media release 2021 Novartis Media release 2019 Novartis Media...

The Novartis Foundation (formerly known as the Novartis Foundation for Sustainable Development) is a non-profit organization and part of the corporate...

to form Novartis. At Sandoz, he worked in research and development and became head of development in 1994. Following the merger into Novartis, Reinhardt...

majority ownership through a joint venture transaction with Novartis. On January 9, 2012, Novartis announced that it was voluntarily recalling all lots of...

Retrieved 11 April 2024. "US SEC FORM 20-F NOVARTIS AG filed January 31, 2007" (PDF). www.novartis.com. NOVARTIS Inc. 31 January 2007. Retrieved 11 April...

arthritis. It binds to the protein interleukin (IL)-17A and is marketed by Novartis. Secukinumab is used to treat psoriasis, ankylosing spondylitis, and psoriatic...

Trustees Novartis Foundation. Novartis Foundation confirms new members of its Board of trustees, including new Chairman Dr. Joerg Reinhardt Novartis Foundation...

hemoglobinuria (PNH). It is a complement factor B inhibitor that was developed by Novartis. It is taken by mouth. Iptacopan was approved by the US Food and Drug Administration...

6, 2008, Novartis agreed to purchase approximately 74 million shares of Alcon from Nestlé at $143.18 per share. On January 4, 2010, Novartis agreed to...

premium. On January 22, 2018, Novartis AG announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A. AAA was...

global plant", Grimsby Telegraph, 16 August 2011, retrieved 23 August 2014 "Novartis Active Pharmaceutical Ingredients, United Kingdom", www.pharmaceutical-technology...

Team". Fiercepharma. "Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints...

The company is located in Mississauga, Ontario. It is a subsidiary of Novartis. The company was founded in 1919 by William Knapp Buckley (1890–1978),...

whistleblower informed Novartis that certain studies of the medication had been subject to data manipulation. In a filing to the FDA, Novartis said that two executives...

on emerging markets. In April 2014, Novartis and Glaxo agreed on more than US$20 billion in deals, with Novartis selling its vaccine business to GSK and...

inactivated vaccine prepared in cell cultures manufactured by Novartis. In April 2007, Novartis received a positive opinion supporting European Union approval...

Company in late 2018. In May 2019 Novartis reached an agreement to purchase the assets associated with Lifitegrast. Novartis will pay Takeda an upfront payment...

supplies of Coartem met demand which enabled Novartis to further decrease the price of Coartem. In April 2008, Novartis further reduced the public sector price...